. . "ensayu cl\u00EDnicu"@ast . . . . . . . . . . . "Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer"@en . . . . . . . . . . . . . . . . "A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . "NCT01547741" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2019-12-01T00:00:00Z"^^ . . . . . . . . . . . . . . "Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer"@en . . . . . . . . . . . . . . . . . "clinical trial"@en . . . "2012-04-01T00:00:00Z"^^ . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . "1871"^^ . . . . . . . . . . . . . . . . . . . . . . "Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer"@en . . . . . . . . . "18"^^ . . . . "klinisch onderzoek"@nl . . . . .